Manorama Industries Ltd

AI

Manorama Industries Ltd

₹ 1,878 -0.06%
17 Nov - close price
About

Manorama Industries is engaged in manufacturing specialty fats and butter made from exotic seeds and nuts. [1]

Key Points

Business Profile:[1]
Manorama Industries is a manufacturer of specialty fats and butters derived from Sal
and Mango seeds. The company follows a "Waste to Wealth" business model: it procures exotic tree-borne seeds, processes them and manufactures cocoa butter equivalents (CBE) and specialty fats for the food, chocolate, confectionery and cosmetics industries.

  • Market Cap ₹ 11,834 Cr.
  • Current Price ₹ 1,878
  • High / Low ₹ 2,162 / 1,061
  • Stock P/E 39.8
  • Book Value ₹ 214
  • Dividend Yield 0.04 %
  • ROCE 35.4 %
  • ROE 40.2 %
  • Face Value ₹ 2.00

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 74.0% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.7%
  • Debtor days have improved from 32.2 to 15.1 days.
  • Company's median sales growth is 34.0% of last 10 years

Cons

  • Stock is trading at 8.79 times its book value
  • Promoter holding has decreased over last quarter: -2.94%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
118 98 129 133 195 209 233 290 323 363 382 404 456
99 83 109 107 150 154 169 211 236 264 279 295 336
Operating Profit 18 16 21 27 45 55 64 79 88 98 103 109 120
OPM % 16% 16% 16% 20% 23% 26% 27% 27% 27% 27% 27% 27% 26%
2 4 4 4 3 2 9 5 1 11 -5 16 15
Interest 5 6 7 8 8 11 12 9 8 11 9 10 11
Depreciation 3 4 4 4 6 6 6 6 6 6 7 6 6
Profit before tax 12 11 14 18 35 40 55 69 74 92 81 109 118
Tax % 30% 30% 10% 26% 24% 27% 23% 27% 26% 25% 26% 25% 26%
9 7 12 14 27 30 42 51 55 68 60 82 88
EPS in Rs 1.44 1.25 2.10 2.27 4.48 4.95 7.09 8.48 9.19 11.43 9.97 13.66 13.91
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
133 131 145 210 102 188 203 279 351 457 771 1,358 1,605
129 127 143 193 73 144 168 240 294 384 580 990 1,174
Operating Profit 4 4 3 17 29 44 35 39 56 74 191 368 430
OPM % 3.2% 3.0% 1.9% 8% 28% 23% 17% 14% 16% 16% 25% 27% 27%
1 1 1 2 3 6 6 8 6 13 19 11 37
Interest 3 2 1 2 5 10 10 6 9 20 39 38 42
Depreciation 1 1 1 1 1 8 8 8 11 14 22 26 26
Profit before tax 2 2 2 16 27 32 22 34 43 53 148 316 399
Tax % 34% 36% 33% 38% 28% 28% 35% 28% 31% 25% 24% 26%
1 1 1 10 19 23 15 24 30 40 112 233 297
EPS in Rs 0.28 0.30 0.36 2.57 3.43 4.20 2.62 4.05 5.00 6.73 18.80 39.06 48.97
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 8% 6% 3% 2%
Compounded Sales Growth
10 Years: 26%
5 Years: 46%
3 Years: 57%
TTM: 52%
Compounded Profit Growth
10 Years: 70%
5 Years: 74%
3 Years: 99%
TTM: 68%
Stock Price CAGR
10 Years: %
5 Years: 46%
3 Years: 65%
1 Year: 40%
Return on Equity
10 Years: 24%
5 Years: 25%
3 Years: 30%
Last Year: 40%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 2 2 2 8 11 11 11 12 12 12 12 12 13
Reserves 8 11 12 17 93 116 134 256 286 325 450 683 1,336
4 5 0 18 24 119 85 108 110 346 482 355 518
3 3 8 3 5 42 24 19 16 53 41 150 111
Total Liabilities 17 21 23 45 133 289 254 396 424 737 985 1,200 1,977
3 3 3 3 6 51 57 55 97 129 176 195 202
CWIP 0 0 0 1 16 0 0 42 50 42 5 18 12
Investments 0 0 0 0 0 0 0 0 0 0 0 10 35
14 18 20 41 112 237 197 299 278 565 804 977 1,728
Total Assets 17 21 23 45 133 289 254 396 424 737 985 1,200 1,977

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2 -11 -11 -60 33 -33 59 -154 -59 259
2 -1 -50 -10 11 -35 -99 -62 -34 -87
-1 16 62 85 -45 117 -7 214 93 -165
Net Cash Flow 3 3 2 15 -0 49 -47 -1 0 7
Free Cash Flow 1 -14 -32 -91 29 -93 8 -193 -90 206
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 72% -47% -16% -126% 121% -56% 126% -188% -15% 93%

Ratios

Standalone / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 3 1 3 3 50 32 40 33 29 33 48 15
Inventory Days 10 18 6 37 273 669 391 535 272 586 516 356
Days Payable 5 5 21 0 11 147 24 24 7 60 13 40
Cash Conversion Cycle 8 14 -13 40 312 553 408 544 294 559 551 331
Working Capital Days 0 -0 -11 2 94 56 128 172 119 100 105 100
ROCE % 27% 24% 17% 62% 37% 22% 14% 13% 13% 13% 23% 35%

Insights

In beta
Mar 2019 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Revenue Share
%

Log in to view insights

Please log in to see hidden values.

Login
Solvent Fractionation Installed Capacity
MTPA
Value-Added Product (CBE + Stearin) Share of Revenue
%
Number of International Subsidiaries
count
Solvent Fractionation Capacity Utilization
%
Top 5 Customer Concentration
% of TOI
Number of Countries Served
count
Stearin + CBE Production Volume
MT

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
57.26% 57.26% 57.26% 57.26% 54.42% 54.42% 54.41% 54.32% 54.32% 54.32% 54.32% 51.38%
2.81% 2.53% 2.16% 2.37% 2.53% 2.81% 3.40% 2.52% 2.71% 2.89% 3.22% 4.16%
2.55% 2.51% 1.74% 1.79% 4.70% 5.14% 4.61% 4.45% 3.61% 3.00% 2.63% 6.40%
37.40% 37.69% 38.83% 38.58% 38.35% 37.64% 37.56% 38.71% 39.36% 39.78% 39.83% 38.05%
No. of Shareholders 8,04814,27914,04014,50618,15219,93824,61732,67134,70336,33533,84140,805

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Annual reports

Concalls